Jacqueline Evans, M.D., Ph.D.

Jacqueline Meryl Evans, M.D., Ph.D.


Pediatric Critical Care




  • Assistant Professor
To see if Jacqueline Meryl Evans is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Children's Hospital

2315 Stockton Blvd.
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Clinical Interests

I am interested in researching ways to improve the care of children with complex congenital heart disease including those who require extracorporeal life support.


Pediatric Critical Care

Center/Program Affiliation

UC Davis Children's Hospital


M.D., University of Massachusetts Medical School, Worcester, Massachusetts, 1993

Ph.D., City University of New York, New York, New York, 1990

B.A./B.S., University of Rochester, Rochester, New York, 1984


Children?s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 1996


Children?s Hospital and Regional Medical Center, Seattle, Washington, 2004

Board Certifications

American Board of Pediatrics, Critical Care Medicine, 2006

American Board of Pediatrics, General Pediatrics, 2010

Professional Memberships

American Academy of Pediatrics

California Thoracic Society

Massachusetts Medical Society

Society for Critical Care Medicine

Honors and Awards

Pasadena Top Doctors, 2010

Sigma Xi, Mt. Sinai School of Medicine Chapter, 1988

Select Recent Publications

Doki T, Mello M, Mock D, Evans JM and Kearns-Jonker, M., Intragraft gene expression profile associated with the induction of tolerance, BMC Immunol. 2008 Feb 11;9:5.

Evans JM , Doki T, Fischer-Lougheed J, Davicioni E and Kearns-Jonker M, WTC06: Expression Changes in Tolerant Cardiac Allografts after Gene Therapy with a Lentiviral Vector Expressing ?1,3 Galactosyltransferase, Transplantation Proceedings, 38:3172-3180, 2006.

Evans J and Cohen G, Catecholamine Uptake Inhibitors Elevate 6-Hydroxydopamine in Brain After Administration of 6-hydroxydopa. Eur J Pharmacol, 232:241-245, 1993.

Cohen G and Evans J, Vesicular Binding of 6-Hydroxydopamine Does Not Explain the Resistance of Dopamine Nerve Terminals to 6-Hydroxydopa. Neurodegeneration, 1:241-246, 1992.

Evans JM and Cohen G, Can Trace Amounts of Neurotoxins Destroy Dopamine Neurons? Neurochemistry International, 15:127-129, 1989.

Evans JM and Cohen G, Studies on the Formation of 6-Hydroxydopamine in Brain After the Administration of 2,4,5-Trihydroxyphenylalanine (6-HydroxyDOPA). J. Neurochem, 52:1461-1467, 1989.